butorphanol has been researched along with Morphine Dependence in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howes, JF; Kotick, MP; Osgood, PF; Polazzi, JO; Razdan, RK; Schut, RN; Villarreal, JE | 1 |
| Bousquet, AR; Howes, JF; Kotick, MP; Polazzi, JO | 1 |
| Kotick, MP; Leland, DL | 1 |
| Grechko, OY; Litvinov, LA; Rashchenko, AI; Shtareva, DM; Spasov, AA | 1 |
| Ho, IK; Rockhold, RW; Sinchaisuk, S | 1 |
| Howlett, GJ; McCarthy, PS | 1 |
| Khazan, N; Steinfels, GF; Young, GA | 1 |
| Feng, Y; Ho, IK; Tokuyama, S; Wakabayashi, H | 2 |
| Fukase, H; Fukuzaki, K; Koja, T; Lukas, SE; Nagata, R | 1 |
| Ho, IK; Hoskins, B; Tokuyama, S; Wakabayashi, H | 1 |
| Ho, IK; Tokuyama, S | 1 |
| Feng, YZ; Ho, IK; Rockhold, RW; Tokuyama, S; Zhang, T; Zhu, H | 1 |
| Feng, Y; Ho, IK; Rockhold, RW | 1 |
| Feng, YZ; Ho, IK; Tokuyama, S; Wakabayashi, H; Zhu, H | 1 |
| He, Z; Ho, IK; Tsang, BK; Wongchanapai, W | 1 |
| He, Z; Ho, IK; Ma, T; Tsang, BK; Wongchanapai, W | 1 |
| Greenwald, MK; Stitzer, ML | 1 |
| Ho, IK; Horan, P | 2 |
| Marynowski, ME; Schmidt, WK; Smith, C | 1 |
| Gmerek, DE; Woods, JH | 1 |
1 trial(s) available for butorphanol and Morphine Dependence
| Article | Year |
|---|---|
Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
Topics: Adult; Arousal; Brain; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Heroin Dependence; Humans; Hypnotics and Sedatives; Lorazepam; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1998 |
21 other study(ies) available for butorphanol and Morphine Dependence
| Article | Year |
|---|---|
Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones.
Topics: Acetates; Analgesics; Animals; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders | 1980 |
Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Substance Withdrawal Syndrome | 1981 |
Analgesic narcotic antagonists. 4. 7-Methyl-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Humans; Morphinans; Morphine Dependence; Narcotic Antagonists; Substance Withdrawal Syndrome | 1980 |
STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE.
Topics: Analgesics; Analgesics, Opioid; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Drug Administration Schedule; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Morpholines; Naloxone; Narcotic Antagonists; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 2016 |
Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Topics: Animals; Basal Ganglia; Butorphanol; Diffusion; Electric Stimulation; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome | 2002 |
Physical dependence induced by opiate partial agonists in the rat.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Butorphanol; Humans; Male; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Nociceptors; Rats; Rats, Inbred Strains | 1984 |
Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
Topics: Animals; Butorphanol; Female; Humans; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Pentazocine; Rats; Rats, Inbred Strains; Self Administration; Sleep, REM; Substance Withdrawal Syndrome | 1982 |
Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Opioid-Related Disorders; Pons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
Topics: Animals; Behavior, Animal; Buprenorphine; Butorphanol; Haloperidol; Imipramine; Macaca fascicularis; Male; Morphine; Morphine Dependence; Naloxone; Psychotropic Drugs; Substance Withdrawal Syndrome | 1994 |
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Behavior, Animal; Butorphanol; Cytosol; Enzyme Inhibitors; Isoquinolines; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Piperazines; Pons; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
Topics: Animals; Biogenic Amines; Biogenic Monoamines; Brain Chemistry; Butorphanol; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
Topics: Animals; Butorphanol; Drug Evaluation, Preclinical; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Substance Withdrawal Syndrome | 1996 |
Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Topics: Animals; Butorphanol; Excitatory Amino Acids; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1997 |
The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Butorphanol; Glutamic Acid; Infusions, Parenteral; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Motor Activity; Naloxone; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine; Morphine Dependence; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord; Substance Withdrawal Syndrome | 1998 |
Supersensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence.
Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine Dependence; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance-Related Disorders | 1998 |
The physical dependence liability of butorphanol: a comparative study with morphine.
Topics: Animals; Behavior, Animal; Body Weight; Butorphanol; Injections, Intraventricular; Male; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Butorphanol precipitates abstinence in morphine dependent rats.
Topics: Animals; Butorphanol; Dose-Response Relationship, Drug; Male; Morphinans; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1989 |
Nalbuphine, pentazocine, and butorphanol interactions with tripelennamine in mice.
Topics: Animals; Butorphanol; Drug Synergism; Mice; Morphinans; Morphine Dependence; Motor Activity; Nalbuphine; Pentazocine; Tripelennamine | 1986 |
Substitution and primary dependence studies in animals.
Topics: Animals; Behavior, Animal; Benzomorphans; Buprenorphine; Butorphanol; Codeine; Discrimination, Psychological; Humans; Macaca mulatta; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Narcotic Antagonists; Pentazocine; Piperidines; Substance Withdrawal Syndrome | 1985 |